Abiopharma

Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference

PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

DARZALEX® (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple myeloma

Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML

New Form 6-K - GSK plc Filed: 2025-06-20 AccNo: 0001654954-25-007230 Size: 44 KB

New Form 6-K - Concord Medical Services Holdings Ltd Filed: 2025-06-20 AccNo: 0001104659-25-060893 Size: 11 KB

New Form 6-K - Haleon plc Filed: 2025-06-20 AccNo: 0001654954-25-007228 Size: 33 KB

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025 USA - English USA - English

New Form 6-K - GSK plc Filed: 2025-06-20 AccNo: 0001654954-25-007222 Size: 1 MB

New Form S-8 - HARROW, INC. Filed: 2025-06-20 AccNo: 0001641172-25-015728 Size: 240 KB

New Form 8-K - Kalaris Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143202 Size: 143 KB Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Item 8.01: Other Events

New Form 8-K - Avalo Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001628280-25-032232 Size: 3 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - EyePoint Pharmaceuticals, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088169 Size: 286 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and …

New Form 6-K - GSK plc Filed: 2025-06-20 AccNo: 0001654954-25-007211 Size: 2 MB